An Analysis from the ICGG Gaucher Registry: A Report of Gaucher Patients Affected by Reduced Doses of Imiglucerase

被引：0
|
作者：
Cole, Alexander [1 ]
Weinreb, Neal [2 ]
Rosenbloom, Barry [3 ]
Andersson, Hans [4 ]
Tripuraneni, Radhika [1 ]
Belmatoug, Nadia [5 ]
机构：
[1] Genzyme Corp, Cambridge, MA USA
[2] Univ Res Fdn Lysosomal Storage Disorders, Coral Springs, FL USA
[3] Tower Hematol Oncol Med Grp, Beverly Hills, CA USA
[4] Tulane Univ, New Orleans, LA 70118 USA
[5] Hop Beaujon, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
159
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [21] Long-Term Data From the ICGG Gaucher Registry: Clinical Parameters After 10 Years of Treatment with Imiglucerase
    Weinreb, Neal J.
    vom Dahl, Stephan
    Cappellini, Maria Domenica
    BLOOD, 2009, 114 (22) : 1390 - 1391
  • [22] Real-world outcomes in pregnant imiglucerase-treated patients with Gaucher disease: Data from the global safety database and International Collaborative Gaucher Group (ICGG) Gaucher registry pregnancy sub-registry maintained by Sanofi Genzyme
    Raynor, Lewis
    Batista, Julie
    Carloni, Laura
    Gudivada, Badari
    Lewis, Grace
    Sekulic, Davorka
    Tsang, So-Fai
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S122 - S122
  • [23] Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry
    Grabowski, Gregory A.
    Zimran, Ari
    Ida, Hiroyuki
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 : S12 - S18
  • [24] EFFECT OF THE SUSPENSION OF THE PRODUCTION OF IMIGLUCERASE ON PATIENTS AFFECTED BY GAUCHER DISEASE
    Deroma, L.
    Sechi, A.
    Macor, D.
    Liva, G.
    Dardis, A.
    Ciana, G.
    Bembi, B.
    EPIDEMIOLOGIA & PREVENZIONE, 2011, 35 (5-6): : 182 - 183
  • [25] International Collaborative Gaucher Group (ICGG) Gaucher Registry: 20 years of sustainability and evolution
    Fallet, Shari
    Fitzpatrick, Mary Anne
    Koepper, Catherine
    Pirard, Vinciane
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S39 - S39
  • [26] Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: An analysis of 798 patients from the ICGG Gaucher Registry
    Fairley, C.
    Zimran, A.
    Phillips, M.
    Cizmarik, M.
    Yee, J.
    Weinreb, N.
    Packman, S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 (06) : 738 - 744
  • [27] Clinical and demographic characteristics of 131 patients with neuronopathic Gaucher disease enrolled in the Neurological Outcomes Sub-Registry of the ICGG Gaucher Registry
    Kolodny, Edwin
    Vellodi, Ashok
    El Beshlawy, Amal
    Cole, J. Alexander
    Tylki-Szymanski, Anna
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S27 - S27
  • [28] Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: A study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
    Khan, Aneal
    Hangartner, Thomas
    Weinreb, Neal J.
    Taylor, John S.
    Mistry, Pramod K.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (08) : 1839 - 1848
  • [29] Prevalence of Parkinson's disease (PD) and Possible Parkinsonian Syndrome in Gaucher Disease: Data from the ICGG Gaucher Registry
    Alcalay, R.
    Mistry, P.
    Di Fonzo, A.
    Batista, J.
    Bianculli, P.
    Carwile, J.
    Perichon, G.
    Balwani, M.
    MOVEMENT DISORDERS, 2024, 39 : S752 - S752
  • [30] Incidence of malignancies among adult patients with type I Gaucher disease: Data from a single referral clinic and from the International Gaucher Registry (ICGG).
    Zimran, A
    Rosenbloom, B
    Andersson, HC
    Charrow, J
    Kaplan, P
    Kolodny, EH
    Mistry, P
    Prakash-Cheng, A
    Scott, CR
    Wappner, RS
    Weinreb, NJ
    Elstein, D
    BLOOD, 2003, 102 (11) : 43B - 43B
12345